U.S. flag

An official website of the United States government

NM_000245.4(MET):c.1357G>A (p.Ala453Thr) AND Renal cell carcinoma

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jun 13, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001215812.10

Allele description [Variation Report for NM_000245.4(MET):c.1357G>A (p.Ala453Thr)]

NM_000245.4(MET):c.1357G>A (p.Ala453Thr)

Gene:
MET:MET proto-oncogene, receptor tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7q31.2
Genomic location:
Preferred name:
NM_000245.4(MET):c.1357G>A (p.Ala453Thr)
HGVS:
  • NC_000007.14:g.116731824G>A
  • NG_008996.1:g.64420G>A
  • NM_000245.4:c.1357G>AMANE SELECT
  • NM_001127500.3:c.1357G>A
  • NM_001324401.3:c.1357G>A
  • NM_001324402.2:c.67G>A
  • NP_000236.2:p.Ala453Thr
  • NP_001120972.1:p.Ala453Thr
  • NP_001311330.1:p.Ala453Thr
  • NP_001311331.1:p.Ala23Thr
  • LRG_662t1:c.1357G>A
  • LRG_662:g.64420G>A
  • NC_000007.13:g.116371878G>A
  • NM_001127500.1:c.1357G>A
Protein change:
A23T
Links:
dbSNP: rs1793019219
NCBI 1000 Genomes Browser:
rs1793019219
Molecular consequence:
  • NM_000245.4:c.1357G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127500.3:c.1357G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001324401.3:c.1357G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001324402.2:c.67G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Renal cell carcinoma (RCCP1)
Identifiers:
MONDO: MONDO:0005086; MeSH: D002292; MedGen: C0007134; Human Phenotype Ontology: HP:0005584

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001387575Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jun 13, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV001749722GenomeConnect - Invitae Patient Insights Network
no classification provided
not providedunknownphenotyping only

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedphenotyping only

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001387575.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 945223). This variant has not been reported in the literature in individuals affected with MET-related conditions. This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 453 of the MET protein (p.Ala453Thr).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GenomeConnect - Invitae Patient Insights Network, SCV001749722.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedphenotyping onlynot provided

Description

Variant interpreted as Uncertain significance and reported on 06-26-2019 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 25, 2025